Cytokinetics | CYTK - Ordinary Share Capital



Cytokinetics reported $119.6M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
Acadia Pharmaceuticals USD 167.36M 167.35M Jun/2025
Amgen USD 538M 33.04B Jun/2025
Bayer EUR 982.42M 1.53B Jun/2025
Biogen USD 146.6M 146.5M Jun/2025
Bristol-Myers Squibb USD 2.04B 1.74B Jun/2025
Cytokinetics USD 119.6M 119.48M Jun/2025
Eisai JPY 282.12M 44.7B Jun/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Exelixis USD 270.13M 269.86M Jul/2025
Geron USD 636.92M 636.28M Jun/2025
Halozyme Therapeutics USD 117.62M 117.5M Jun/2025
Ionis Pharmaceuticals USD 159.2M 159.04M Jun/2025
Ligand Pharmaceuticals USD 19.41M 19.39M Jun/2025
Merck USD 1.79B 0 Mar/2025
Novartis USD 793M 0 Dec/2024
Pfizer USD 5.68B 5.2B Jun/2025
Regeneron Pharmaceuticals USD 106.4M 106.4M Jun/2025
Roche Holding CHF 107M 0 Jun/2024
Sanofi 1.22B 36.5M Jun/2025